IMS HEOR experience in the Asia-Pacific region lies in supporting drug reimbursement and in providing and delivering the health outcomes and pharmacoeconomic value message.
Countries in this region provide a unique challenge because of the diversity of cultural and health care financing arrangements. In such circumstances strong technical skills and commercial and strategic awareness are essential.
IMS HEOR have started building relationships with authorities in this region and have driven initial projects.